The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0030
0.00 (0.00%)
Sep 1, 2026, 3:52 PM AEST

ASX:HPC Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.152.473.24.39.16.13
Revenue Growth
-13.05%-22.88%-25.48%-52.74%48.52%63.10%
Gross Profit
1.031.361.621.94.72.79
Operating Income
-2.71-3.15-4.2-6.87-10.7-6.83
Net Income
-2.48-2.862.67-8.1-10.61-8.95
Earnings Per Share
-0.01-0.010.01-0.04-0.07-0.12
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.441.123.221.844.6910.67
Total Debt
---3.893.71-
Net Cash (Debt)
0.441.123.22-2.050.9810.67
Net Cash Growth
-60.40%-65.22%---90.85%548.95%
Net Cash Per Share
0.000.000.01-0.010.010.14

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.97-3.65-3.88-5.73-9.75-8.08
Capital Expenditures
------
Free Cash Flow
-2.97-3.65-3.88-5.73-9.75-8.08
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.72%55.18%50.58%44.18%51.61%45.53%
Operating Margin
-126.14%-127.29%-130.95%-159.62%-117.60%-111.52%
Pretax Margin
-115.34%-111.31%-177.05%-168.07%-116.56%-146.10%
Profit Margin
-115.36%-115.75%83.23%-188.39%-116.56%-146.10%
FCF Margin
-138.15%-147.82%-121.03%-133.22%-107.16%-131.84%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--1.27---
PS Ratio
0.510.581.061.011.105.73